郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor.

期刊：Biochemical pharmacology发表年份：2013作者：Chris J van Koppen; Pieter M Verbost; Ruud van de Lagemaat; Willem-Jan F Karstens; Huub J J Loozen; Tanja A E van Achterberg; Monique G A van Amstel; Jolanda H G M Brands; Els J P van Doornmalen; Jesse Wat; Saskia J Mulder; Bianca C Raafs; Saskia Ver
阅读更多 →

药效评价Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.

期刊：The Journal of biological chemistry发表年份：2013作者：Katrin Sobel; Katalin Menyhart; Nina Killer; Bérengère Renault; Yasmina Bauer; Rolf Studer; Beat Steiner; Martin H Bolli; Oliver Nayler; John Gatfield
阅读更多 →

药效评价Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2013作者：Mathew Belzer; Mark Morales; Bhumasamudram Jagadish; Eugene A Mash; Stephen H Wright
阅读更多 →

药效评价Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.

期刊：Journal of neuroinflammation发表年份：2013作者：Hodaya Prinz-Hadad; Tehila Mizrachi; Michal Irony-Tur-Sinai; Tatyana B Prigozhina; Alexandra Aronin; Talma Brenner; Michal Dranitzki-Elhalel
阅读更多 →